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12 Abstract Processes catalyzed by enzymes offer numerous ad-
13 vantages over chemical methods although in many occasions
14 the stability of the biocatalysts becomes a serious concern.
15 Traditionally, synthesis of nucleosides using poorly water-
16 soluble purine bases, such as guanine, xanthine, or hypoxan-
17 thine, requires alkaline pH and/or high temperatures in order to
18 solubilize the substrate. In this work, we demonstrate that the
19 2′-deoxyribosyltransferase from Leishmania mexicana
20 (LmPDT) exhibits an unusually high activity and stability un-
21 der alkaline conditions (pH 8–10) across a broad range of
22 temperatures (30–70 °C) and ionic strengths (0–500 mM
23NaCl). Conversely, analysis of the crystal structure of
24LmPDT together with comparisons with hexameric, bacterial
25homologs revealed the importance of the relationships between
26the oligomeric state and the active site architecture within this
27family of enzymes. Moreover, molecular dynamics and
28docking approaches provided structural insights into the
29substrate-binding mode. Biochemical characterization of
30LmPDT identifies the enzyme as a type I NDT (PDT),
31exhibiting excellent activity, with specific activity values
32100- and 4000-fold higher than the ones reported for other
33PDTs. Interestingly, LmPDT remained stable during 36 h at
34different pH values at 40 °C. In order to explore the potential
35of LmPDTas an industrial biocatalyst, enzymatic production of
36several natural and non-natural therapeutic nucleosides, such
37as vidarabine (ara A), didanosine (ddI), ddG, or 2′-fluoro-2′-
38deoxyguanosine, was carried out using poorly water-soluble
39purines. Noteworthy, this is the first time that the enzymatic
40synthesis of 2′-fluoro-2′-deoxyguanosine, ara G, and ara H by
41a 2′-deoxyribosyltransferase is reported.
42Keywords 2′-deoxyribosyltransferase . Enzymatic
43synthesis . Industrial biocatalyst . Protein crystallography .
44Molecular docking . Purine nucleoside analogues
45Introduction
46Nucleic acid derivatives (NADs) such as nucleosides, nucle-
47otides, or nucleobases are known to be ubiquitous molecules
48in biochemical processes of storage and genetic transfer of the
49information. Besides, the therapeutic potential and applicabil-
50ity of many NADs to treat diseases or their use as building
51blocks in the synthesis of oligonucleotides is well known (De
52Clerq 2005a, b; Galmarini et al. 2002; Parker 2009; Robak
53et al. 2006). Therefore, many efforts have been made over the
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54 years to improve the synthetic methods to obtain NADs.
55 Conventionally, these molecules have been synthesized by
56 chemical methods, which often require time-consuming mul-
57 tistep processes, including protection–deprotection strategies
58 or the use of chemical reagents and organic solvents that are
59 expensive and environmentally harmful (Boryski 2008). In
60 contrast, the alternative enzymatically based approaches for
61 the synthesis of NADs have gained relevance due to the easy
62 implementation of one-pot one-step reactions under mild con-
63 ditions or environmentally friendly conditions (Lewkowicz
64 and Iribarren 2006; Mikhailopulo 2007; Fresco-Taboada
65 et al. 2013). Hence, the replacement of chemical synthesis
66 by enzymatic or chemo-enzymatic strategies in the industrial
67 synthesis of NADs is frequently observed. In this respect,
68 microbial nucleoside phosphorylases (NPs) and N-
69 deoxyribosyltransferases (NDTs) are extensively used in the
70 synthesis of natural and non-natural nucleosides as biocatalyst
71 for the transfer of glycosyl residues to acceptor bases (Fresco-
72 Taboada et al. 2013).
73 N-deoxyribosyltransferases (EC 2.4.2.6) catalyze the direct
74 transfer of the 2-deoxyribosyl moiety from a 2′-deoxynucleoside
75 donor to a nucleobase acceptor through a one-step reaction
76 (Fresco-Taboada et al. 2013; Kaminski 2002). Nucleoside 2′-
77 deoxyribosyltransferases are classified into two classes depend-
78 ing on their substrate specificity: type I (PDT), which are spe-
79 cific for purines (Pur↔Pur) and type II (NDT), which catalyzes
80 the transfer between purines and/or pyrimidines (Pur↔Pur,
81 Pur↔Pyr, Pyr↔Pyr) (Fresco-Taboada et al. 2013; Fernández-
82 Lucas et al. 2010). AlthoughNDTs are regio- (N-1 glycosylation
83 in pyrimidine and N-9 in purine) and stereoselective (exclusive-
84 ly the β -anomers a re formed) enzymes for 2 ′ -
85 deoxyribonucleosides, recent studies have revealed that some
86 NDTs can recognize substrates containing modifications at po-
87 sitions 2′C and 3′C of the deoxyribose moiety (Fresco-Taboada
88 et al. 2013; Kamisnki et al. 2008).
89 Enzymatic synthesis of natural and non-natural nucleosides
90 using poorly water-soluble purine bases is hindered by the low
91 solubility of some purines, such as guanine, hypoxanthine, or
92 xanthine, which may cause underperformance of the biocata-
93 lyst (Yokozeki and Tsuji 2000; Okuyama et al. 2003).
94 Traditionally, to circumvent this limitation, high temperature
95 and alkaline conditions were used, resulting in a higher solu-
96 bilization of substrates, a diminution of medium-viscosity, and
97 an increase of substrate diffusion coefficients, leading to
98 higher overall reaction rate. Unfortunately, neither PDT nor
99 NDT enzymes exhibit high catalytic activities under basic pH
100 values or high temperatures. Okuyama et al. (2003) have ap-
101 plied a smart approach by coupling the production 2,6-
102 diaminopurine-2 ′-deoxyriboside by the NDT from
103 Lactobacillus helveticus (LhNDT) with a bacterial adenosine
104 deaminase (EcADA) for the ensuing hydrolytic step to obtain
105 2′-deoxyguanosine (dGuo) in high yields. Complementarily,
106 the addition of water-miscible organic solvents to the reaction
107media to improve the solubility of guanine has been described
108(Yokozeki and Tsuji 2000;Müller et al. 1996). As an example,
109we have recently reported the effect of several water-miscible
110co-solvents on the activity and stability of free and
111immobilized 2′-deoxyribosyltransferase from Lactobacillus
112reuteri in order to establish the optimal conditions for enzy-
113matic synthesis of nucleosides using poorly water-soluble pu-
114rine bases (Fernández-Lucas et al. 2012).
115Here, we have carried out thorough structural and biochem-
116ical studies of the 2′-deoxyribosyltransferase type I from
117Leishmania mexicana (LmPDT). Structurally, the comparison
118of the dimeric assembly of LmPDT with bacterial, hexameric
119homologs has revealed unexpected features of the active site
120architecture of these enzymes. Conversely, as a biocatalyst,
121LmPDT presents significant stability and catalytic activity un-
122der alkaline and high temperature experimental conditions,
123displaying high activity values compared to other reported
124PDTs (Kaminski 2002; Lawrence et al. 2009). These unusual
125catalytic properties together with the promiscuity in the rec-
126ognition of the sugar moiety showed by LmPDT allowed the
127synthesis of different purine nucleoside analogues from poor-
128ly soluble purine bases. To the best of our knowledge, this is
129the first time that enzymatic synthesis of ara G, ara H, and 2′-




134Cell culture medium reagents were from Difco (St. Louis,
135MO). Trimethylammonium acetate buffer were purchased
136from Sigma-Aldrich. All other reagents and organic solvents
137were purchased to Scharlab (Barcelona, Spain) and Symta
138(Madrid, Spain). All NADs (nucleosides and nucleobases)
139used in this work were provided by Carbosynth Ltd.
140(Compton, UK).
141Gene cloning and expression and protein production
142and purification
143The synthetic pdt gene encoding the putative PDT from
144L. mexicana (European Nucleotide Archive code:
145CBZ27326.1; UniProtKB code E9AWJ0) was ordered and
146purchased from Genscript (USA). The coding sequence ap-
147peared as a NdeI-EcoRI fragment subcloned into the expres-
148sion vector pET28b(+). The resultant, recombinant vector
149pET28bLmPDT provided the corresponding N-terminal
150His6-tagged fusion protein with a thrombin cleavage site be-
151tween the tag and the enzyme. The recombinant enzyme was
152produced in Escherichia coli BL21(DE3) grown in LB medi-
153um at 37 °C with kanamycin 50 μg/mL. Protein
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154 overexpression was induced by adding 0.5 mM isopropil-β-
155 D-1-thiogalactopyranoside and the cells further grown for 3 h.
156 The cells were harvested via centrifugation at 3500×g. The
157 resulting pellet was resuspended in Tris buffer (20 mM Tris-
158 HCl, pH 8.0, containing 100 mM NaCl). Crude extracts were
159 prepared by French press lysis of cell suspensions. The lysate
160 was centrifuged at 17500×g for 40 min and the supernatant
161 was filtered through a 0.22-μm filter (Millipore). The cleared
162 lysate was then loaded onto a 5-mL HisTrap FF column (GE
163 Healthcare) pre-equilibrated in a binding buffer (20 mM Tris-
164 HCl buffer, pH 8.0, with 100 mM NaCl and 10 mM imidaz-
165 ole) and the column was washed. Bound proteins were eluted
166 using a linear gradient of imidazole (from 10 to 500 mM).
167 Fractions containing LmPDT were identified by SDS-PAGE,
168 pooled, concentrated, and loaded onto a HiLoad 16/60
169 Superdex 200 prep grade column (GE Healthcare) pre-
170 equilibrated in Tris buffer. Fractions with the protein of inter-
171 est identified by SDS-PAGE were pooled and the protein was
172 concentrated and stored at −80 °C until its use. Protein con-
173 centration was determined spectrophotometrically by UV ab-
174 sorption at 280 nm using a ε280 = 34,380 M
−1 cm−1 (Gill and
175 Von Hippel 1989).
176 N-deoxyribosyltransferase assay
177 The standard enzymatic activity assay was performed in a final
178 volume of 40 μL by addition to the pure enzyme (0.3 μg of in
179 50 mM MES buffer, pH 6.5) the substrate (dGuo or Ade
180 10 mM in 50 mM MES buffer, pH 6.5) for 5 min at 40 °C
181 (30 rpm). The enzymatic reaction was quenched by addition of
182 40 μL of cold methanol in ice-bath and heated for 5 min at
183 95 °C as described previously (Fernández-Lucas et al. 2010;
184 Fernández-Lucas et al. 2012). After centrifugation at 9000×g
185 for 2 min, samples were half-diluted with water and the nucle-
186 oside production was analyzed by HPLC to quantitatively
187 measure the reaction products as described below in the ana-
188 lytical methods. All determinations were carried out by tripli-
189 cate and the maximum error was below 5%. In such condi-
190 tions, one international activity unit (IU) was defined as the
191 amount of enzyme producing 1 μmol/min of 2 ′-
192 deoxyadenosine under the assay conditions.
193 Analytical methods
194 Production of nucleosides was analyzed quantitatively with an
195 ACE 5 μm C18-PFP column 250 mm × 46 mm (Advanced
196 Chromatography Technologies) pre-equilibrated in 100%
197 trimethyl ammonium acetate. Elution was carried out by a
198 discontinuous gradient, 0–10 min, 100 to 90% trimethyl am-
199 monium acetate and 0 to 10% acetonitrile, and 10–20 min, 90
200 to 100% trimethyl ammonium acetate and 10 to 0% acetoni-
201 trile. Retention times for the reference natural compounds
202 (hereafter abbreviated according to the recommendations of
203the IUPAC-IUB Commission on Biochemical Nomenclature)
204were as follows: adenine (Ade): 10.14 min; 2′-deoxyadenosine
205(dAdo), 15.50 min; guanine (Gua), 8.1 min; 2 ′-
206deoxyguanosine (dGuo), 12.8 min; hypoxanthine (Hyp),
2077.5min; and 2′-deoxyinosine (dIno), 12.1min. Retention times
208for the reference non-natural compounds (hereafter abbreviat-
209ed according to the recommendations of the IUPAC-IUB
210Commission on Biochemical Nomenclature) were as follows:
211ara adenine (ara A), 14.0 min; ara guanine (ara G), 11.4; ara
212hypoxantine (ara H), 11.0; 2′-deoxy-2′-fluoroadenosine
213(2’dFAdo), 17.0; 2′-deoxy-2′-fluoroguanosine (2’dFGuo),
21413.6; 2′-deoxy-2′-fluoroinosine (2’dFIno), 13.3; 2′,3′-
215dideoxyadenosine (ddA), 19.0 min; 2′,3′-dideoxyiguanosine
216(ddG), 15.3 min; and 2′,3′-dideoxyinosine (ddI), 14.8 min.
217Biochemical characterization
218The optimal temperature for enzyme activity was determined
219by measuring the activity of LmPDT between 20 and 90 °C
220using the N-deoxyribosyltransferase assay. The optimal pH for
221enzyme activity was also determined by measuring the activity
222in the pH range from 4 to 10, incubating 0.3μg of pure enzyme
223with 10 mM 2′-deoxyguanosine (dGuo) and 10 mM adenine
224(Ade) in different reaction buffers (sodium citrate, pH 4–6;
225sodium phosphate, pH 6–8; sodium borate, pH 8–10) using
226standard reaction conditions. A similar approach has been
227followed to characterize the effect of ionic strength on enzyme
228activity. LmPDT activity has been measured at different con-
229centrations of NaCl, ranging from 0 to 1000 mM.
230The thermal stability of LmPDTwas studied by incubating
231enzyme solutions (60 μg/ml in 50 mMMES buffer, pH 6.5, or
232in 50 mM sodium borate buffer, pH 8.5), at temperatures
233ranging from 40 to 50 °C. At regular intervals, 5 μL aliquots
234were withdrawn from the incubation mixture and the residual
235activity was determined at 40 °C using dAdo synthesis from
236dGuo and Ade under the standard assay conditions.
237Enzymatic synthesis of natural and non-natural purine
238nucleosides from low soluble water purine bases
239Enzymatic synthesis of natural nucleosides was performed as
240described for N-deoxyribosyltransferase assay using different
241purine 2′-deoxyribonucleosides and bases (10 mM).
242Enzymatic synthesis of non-natural nucleosides was carried
243out incubating 3.0 μg of LmPDTwith modified purine nucle-
244osides (arabinosyl nucleosides, 2′-deoxy-2′-fluoronucleosides
245and 2′,3′-dideoxyribosylnucleosides) and natural purine bases
246at different conditions.
247Enzyme crystallization and data collection
248Crystallization of LmPDT (15 mg/mL in Tris buffer) was per-
249formed on VDX hanging drop plates (Hampton Research) at
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250 291 K. Crystal plates grew in 25% PEG 3350, 0.2 M magne-
251 sium chloride, 0.1 M Tris-HCl, pH 8.5 (protein/precipitant
252 drop ratio 2:1) by vapor diffusion.
253 For diffraction data collection, LmPDT crystals were trans-
254 ferred to an optimized cryoprotectant solution consisting of
255 mother liquor plus 20% (v/v) glycerol before being cooled to
256 100 K in a cold nitrogen-gas stream. Diffraction data were
257 collected on beamline BL13-XALOC at the ALBA synchro-
258 tron (Barcelona, Spain) with a Pilatus 6M detector (Area
259 Detector Systems Corp.) and a crystal-to-detector distance of
260 242.38mm.A total of 1440 imageswere collected with a 0.25°
261 oscillation angle. Diffraction images were processed with XDS
262 (Kabsch 2010) and the space group examination was per-
263 formed with POINTLESS (Evans 2011). Crystals of LmPDT
264 belonged to the monoclinic space group C2, with two mole-
265 cules in the asymmetric unit and 36% solvent content within
266 the unit cell. A summary of data collection statistics is provided
267 in Table 1.
268Structure solution and refinement
269The structure of LmPDTwas solved bymolecular replacement
270using phenix.phaser (McCoy 2007). The atomic coordinates
271of nucleoside 2′-deoxyribosyltransferase from Trypanosoma
272brucei were used as search model (TbNDT; PDB entry
2732A0K). Model rebuilding was performed manually using
274COOT (Emsley et al. 2010) and refinement was carried out
275with phenix.refine (Afonine et al. 2012) in PHENIX (Adams
276et al. 2010). Refinement steps included xyz refinement, TLS,
277individual atomic displacement parameters (ADPs), addition
278of ligands, and solvent molecules. The refined structure has a
279final R-factor of 16.8% (Rfree = 20.5%) for data up to 1.66 Å.
280Analysis of the interfacial surfaces was done with the PISA
281server (Krissinel and Henrick 2007). Analysis of the second-
282ary structure was done with DSSP (Touw et al. 2015).
283Stereochemistry validation was done with the Phenix
284MolProbity tool plus de wwPDB Deposition server. PyMOL
285(DeLano 2002) was used for structure visualization and figure
286preparation. Data collection and refinement statistics are listed
287in Table 1.
288Computational methods
289Optimized geometries of the complex LmPDT with 2′-
290deoxyadenosine (dAdo) and Glu85-ribosylated form of the
291enzyme were achieved following a restrained molecular dy-
292namics (MD) protocols using the Amber14 suite of programs
293(Case et al. 2014). The X-ray crystal structure of L. helveticus
294purine 2′-deoxyribosyltransferase (LhPDT) in complex with
295dAdo (PDB entry 1S2G (Anand et al. 2004) was
296superimposed onto the crystal structure of LmPDT with
297PyMOL (DeLano 2002) and dAdo was manually docked into
298the binding site. Geometry optimization of dAdo and the
299ribosylated Glu85 was achieved in vacuo using the RESP
300ESP charge Derive Server (Vanquelef et al. 2011) following
301the standard procedure. The input files for dAdo and the
302ribosylated Glu85 were generated using the anterchamber
303utility included in the AMBER14 suite (Case et al. 2014).
304The conformation of the loop 43-46 of LmPDT in the pres-
305ence of dAdo was modeled by means of unrestrained MD
306simulations at 300 K and 1 atm. All the positions of the Cα
307atoms of the protein, except those of the former loop, were
308restrained by imposing a harmonic force constant of 5 kcal
309mol−1 Å−2. In all systems, the protein was immersed in a box
310of ~ 17,000 TIP3P water molecules that extended 25 Å away
311from any solute atom and 12 Na+ ions were added to ensure
312electrical neutrality. The MD simulation was carried out as
313described before (Sánchez-Murcia et al. 2016) using the
314pmemd_cuda.SPFP module and the standard ff14SB force
315field parameter set in AMBER14. Our in-house MM-ISMSA
316program (Klett et al. 2012) was then employed on a set of 150
317snapshots from the MD trajectory of the LmPDT/dAdo
t1:1 Table 1 Data collection and refinement statistics
t1:2 LmPDT
t1:3 PDB code 5NBR
t1:4 Data collection
t1:5 Synchrotron source ALBA
t1:6 Beamline BM13-XALOC
t1:7 Wavelength (Å) 0.9793
t1:8 Space group C2
t1:9 Unit-cell parameters a = 80.2, b = 46.3, c = 87.9
α = 90°, β = 115.1°, γ = 90°
t1:10 Resolution range (Å) 39.85–1.66
t1:11 No. of measured reflectionsa 228,772 (11,234)
t1:12 No. of unique reflections 33,859 (1595)
t1:13 Mean (I/σI) 18.3 (3.1)
t1:14 Completeness (%) 97.7 (96.4)
t1:15 Multiplicity 6.8 (7.0)
t1:16 Rmeas (%); Rpim (%) 5.2 (64.5); 2.8(33.8)





t1:22 Rwork (%)/Rfree (%) 16.8/20.3
t1:23 Average B-factors (Å2)
t1:24 Protein 31.7
t1:25 Water 35.2
t1:26 Rms deviation bond length (Å) 0.007
t1:27 Rms deviation angles (°) 0.788
t1:28 Ramachandran
t1:29 Favored (%) 95.4
t1:30 Disallowed (%) 0.33
a Values for the highest resolution shell are given in parentheses
Appl Microbiol Biotechnol















318 complex to calculate the solvent-corrected binding energies at
319 the dimer interface of the protein. The affinity maps were com-
320 puted with program cGRILL (Cortés-Cabrera et al. 2015).
321 Analytical ultracentrifugation
322 Sedimentation velocity for LmPDT were carried out in 20 mM
323 Tris-HCl, pH 8.0 at 20 °C and 50,000×g in an Optima XL-I
324 analytical ultracentrifuge (Beckman-Coulter Inc.), equipped with
325 UV-VIS absorbance and Raleigh interference detection systems,
326 using an An-60Ti rotor and standard (12-mm optical path)
327 double-sector center pieces of Epon-charcoal. Sedimentation
328 profiles were recorded at 292 nm. Sedimentation coefficient dis-
329 tributions were calculated by least-squares boundarymodeling of
330 sedimentation velocity using the continuous distribution c(s)
331 Lamm equation model as implemented by SEDFIT 14.7g.
332 Baseline offsets were measured afterwards at 200,000×g.
333 The apparent sedimentation coefficient of distribution, c(s),
334 and sedimentation coefficient s were calculated from the sed-
335 imentation velocity data using the program SEDFIT (Brown
336 and Schuck 2006). The experimental sedimentation coeffi-
337 cients were corrected to standard conditions (water, 20 °C,
338 and infinite dilution) using the software SEDNTERP (Laue
339 et al. 1992) to get the corresponding standard s values (s20,w).
340 Accession number
341 The atomic coordinates and structure factors have been depos-
342 ited in the Protein Data Bank with the accession code: 5NBR.
343 Results
344 Crystallization and structural characterization of LmPDT
345 Optimized crystals of LmPDTwere grown by mixing LmPDT
346 (15 mg/mL in 20 mM Tris-HCl, 0.1 M NaCl pH 8.0) with
347 25% PEG 3350, 0.2 M magnesium chloride, 0.1 M Tris-HCl,
348 and pH 8.5 (protein/precipitant drop ratio 2:1). The high-
349 resolution crystal structure of LmPDT has been determined
350 by molecular replacement using the structure of nucleoside
351 2′-deoxyribosyltransferase from T. brucei (TbNDT; PDB en-
352 try 2A0K) as a search model. The asymmetric unit contained
353 two polypeptide chains with identical structures (the r.m.s.d.
354 for 150 Cα positions is 0.41 Å) that are associated forming a
355 dimeric assembly (see below). The final, refined model of the
356 structure included chain A residues 1–154 and chain B resi-
357 dues 4–153. The 2Fo-Fc electron density map showed contin-
358 uous density for the whole protein, excluding the side chains
359 of chain A residues 43–46, which are located in the β2-α3
360 connecting loop in close proximity to the crystallographic
361 twofold symmetry axis. All residues occupy favorable regions
362of the Ramachandran plot. Data collection and refinement
363statistics are shown in Table 1.
364The LmPDT subunit is a highly asymmetric α/β protein
365composed of a globular core and a large region situated be-
366tweenβ4 strand andα6 helix comprised by residues 102–137,
367which is herein defined as the intersubunit zone (Fig. 1). The
368core of the structure is composed of a central, parallel, four-
369stranded β-sheet (with 2134 topology) with two helices
370packed against each of its sides (α2-α6 and α3-α4, respec-
371tively) and a helix turn (α1). Conversely, the intersubunit zone
372protrudes from the core towards the accompanying subunit
373and contains two small β-strands (β5 and β6) and an addi-
374tional helix turn (α5).
375The hydrodynamic behavior of LmPDT studied by sedi-
376mentation velocity experiments showed that the enzyme be-
377haves as a single species in solution with an experimental
378sedimentation coefficient of 3.13 S (s20,w = 3.15) compatible
379with a globular species of 37 kDa. This agrees well with a
380dimeric assembly of LmPDT (theoretical mass of the mono-
381mer 18,706 Da), which is precisely the assembly observed in
382the LmPDTcrystal. The analysis of the protein packing of this
383crystal with the PISA server (Krissinel and Henrick 2007)
384reveals a large contacting interface between subunits
385(~ 4500 Å2) that mainly involves residues from helices α3,
386α4, and α6 from the globular core, and β6 strand from the
387intersubunit zone. Each α6 helix becomes sandwiched be-
388tween helices α3# and α4# (# indicates structural elements
389from the accompanying subunit) and β6 strand rests above
390α1#. Some residues from the large β6-α6 connecting loop
391(residues 120–140), and α6 helix of one subunit form part
392of the substrate-binding pocket of the other subunit, which
393explains that the dimeric assembly is the minimum catalytic
394unit of these enzymes (Armstrong et al. 1996). In agreement
395with this, the hexameric assemblies observed in the bacterial
396homologs (see below) 2′-deoxyribosyltransferase from
397Lactobacillus leichmannii (LlNDT) (Armstrong et al. 1996)
398and 2′-deoxyribosyltransferase type I from L. helveticus
399(LhPDT) (Anand et al. 2004) are trimers of dimers.
400The global energy of interaction of the dimer interface was
401analyzed in silico and decomposed by residue using the ap-
402proach MM-ISMSA (Klett et al. 2012). In Table S1 are listed
403those residues that contribute the most to the stability of the
404dimer along a molecular dynamics (MD) protocol where all
405the alpha-carbon have been positional restrained (see section
406Computational methods in Material and methods). Although
407the interaction between the C-terminal carboxylate moiety of
408Leu153 and the side chain of Lys5# has the large contribution,
409the interactions of the side chains of residues located on α4
410helix (Arg74, Phe84, Tyr88) with residues on β6# strand and
411α6# helix (Met130, Leu118, Ser119, Ile131) are also relevant.
412Structural similarity searches using the FATCAT (Ye and
413Godzik 2003) and DALI Lite v3 (Holm and Rosenström 2010)
414servers reveal TbNDT as the closest structural homolog of
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415 LmPDT (r.m.s.d. of 1.04 Å for 150 Cα atoms and a sequence
416 identity of 63%) followed by 2′-deoxyribosyltransferase LlNDT
417 (r.m.s.d. of 3.22 Å for 170 Cα atoms and a sequence identity of
418 18%; PDB entry 1F8Y) and LhPDT (r.m.s.d. of 3.17 Å for 170
419 Cα atoms and a sequence identity of 13%; PDB entry 1S2D). A
420 similar result is obtained using the Dali Lite v3.0 server (Holm
421 and Rosenström 2010) but in this case also appeared the putative
422 nucleoside 2-deoxyribosyltransferase from Enterococcus
423 faecalis (sequence identity of 22%; PDB entry 3EHD).
424 Architecture of the active site
425 The substrate-binding pocket of LmPDT is made up of residues
426 contributed by the two interacting subunits. This feature is a
427 signature of 2′-deoxyribosyltransferases (Fresco-Taboada et al.
428 2013; Armstrong et al. 1996; Anand et al. 2004). The catalytic
429 Glu85, which occupies an equivalent position toGlu82, Glu101,
430 and Glu98 in TbNDT, LhPDTand LlNDT, respectively (Fig. 2),
431 is located deep inside this pocket and hydrogen bonds through
432 its side chain with the OH atom of the Tyr8 side chain.
433 Theoretical computation of the protonation state of the protein
434 at pH 7.5 with the H++ server (Anandakrishnan et al. 2012)
435 shows that Glu85 may be protonated in the unbound state as
436 was previously suggested by Short and co-workers in PDTs of
437 Lactobacilli species (Short et al. 1996). By comparison with
438 LhPDT and LlNDT, it can be inferred that the residues of
439 LmPDT that participate in substrate binding are Asn56,
440Asp79, Thr82, and Asn128# (Fresco-Taboada et al. 2013;
441Armstrong et al. 1996; Anand et al. 2004). Interestingly,
442Asn56 (Asn53 in TbNDT) is replaced by aspartic acid in
443LhPDT and LlNDT (Fig. 2). Conversely Q1, although in the active
444site of LmPDT several hydrophobic residues can be identified
445(Phe15, Ile60, Met281B), the contribution of aromatic residues
446is limited to Phe15 (equivalent to Tyr17 in LhPDT or Phe13 in
447LlNDT), which contrasts to LhPDT and LlNDT that possess
448several aromatic residues (Phe16, Tyr17, and Phe45 in
449LhPDT; Trp12, Phe13, and Tyr21 in LlNDT) (Armstrong et al.
4501996; Anand et al. 2004).
451The detailed analysis of the dimeric complexes of LmPDT
452or TbNDT and its comparison with the hexameric assemblies
453of LhPDT and LlNDT revealed that the stabilization of these
454latter higher order oligomers demands a long α3 helix and
455consequently a long β2-α3 connecting loop of the subunits
456(see Discussion for details). The much shorter α3 helix and
457β2-α3 connecting loop of LmPDT together with the location
458of α1 helix and the presence of the β6-α6 loop from the
459neighbor LmPDT subunit results in a different architecture of
460the substrate-binding pocket when compared to LhPDT or
461LlNDT. Yet this novel arrangement has minor consequences
462in the internal volume of the active sites as determined with
463the CASTp server (Dundas et al. 2006), 810 Å3 in LmPDT
464versus 870 Å3 in LhNDT or 730 Å3 LlNDT, respectively.
465Curiously, these figures contrast with TbNDT, which has a
466larger pocket (1130 Å3). This difference can be attributed to
Fig. 1 Representation of the dimeric assembly of the 2 ′-
deoxyribosyltransferase LmPDT. One subunit of the dimer is shown as
the surface model (yellow corresponds to the globular core and orange
to the intersubunit zone) and the other one as the cartoonmodel (green for
the globular core and blue for the intersubunit zone). The core of each
subunit is composed of a central, parallel, four-stranded β-sheet with two
helices packed against each of its sides (α2-α6 and α3-α4, respectively),
and a helix turn (α1). The intersubunit zone contains the β-strands β5 and
β6 and an additional helix turn (α5). The regular secondary structural
elements of the cartoon model are labeled. The figure has been prepared
with PyMOL (DeLano 2002)
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467 the specific conformation of the β2-α3 connecting loop: thus,
468 whereas in LmPDT this loop is directed towards the pocket, in
469 TbNDT it protrudes to the bulk solvent (Bosch et al. 2006)
470 (Fig. S2 and supplementary video 1). The poor electron den-
471 sity of the side chains of some residues from this loop in
472 LmPDT (Asp43 to Ala46) suggests that this region is flexible
473 and may play a role in substrate binding (see below).
474 The long β6-α6 loop of LmPDT not only covers the
475 substrate-binding pocket of the associated subunit but also
476 contains residues that probably participate in substrate binding
477 such as Asn128. In close proximity to this latter residue is
478 situated Glu121, which occupies an equivalent position to
479 the carboxyl group of the C-terminal Tyr157 that has been
480 shown to play an important catalytic role (Anand et al. 2004).
481 2′-Deoxyadenosine complex
482 With a view to understanding the binding of a nucleoside at
483 the active site of LmPDT, the natural substrate 2 ′-
484 deoxyadenosine (dAdo) was placed into the active site of the
485 enzyme by means of docking and molecular dynamics (MD)
486 protocols (see Computational methods in Materials and
487 Methods). Briefly, the loop 43-46 was allowed to move freely
488 along the MD simulation whereas a force constant of
489 5 kcal mol−1 Å−2 was applied to positional restrain the rest
490 of the Cα atoms of the protein. In the resulting equilibrated
491 structure, the loop 43-48 moves towards the bulk solvent, with
492 the Asp43 side chain adopting a conformation that mimics the
493 Glu50 side chain of TbNDT (Fig. 3a). The interaction pattern
494 shown in this figure reveals that the 2′-deoxyribosyl moiety of
495 the deoxynucleoside is recognized by the side chains of the
496 residues Asp79, Asn128, Glu85 (catalytic residue that is po-
497 sitioned by Tyr8), and Asn56 that participate in a dense net-
498 work of hydrogen bonds (Fig. 3a). Complementary, whereas
499the adenine is recognized by the side chain of Asn56 similarly
500to Asp75 in LhPDT, the amino group 6-NH2 of the adenine
501interacts with the side chain of Glu121# in analogy to the
502carboxylate of the C-terminal Tyr in LhPDT (Anand et al.
5032004), as indicated before.
504The crystal structure of LmPDT reveals a glycerol molecule
505in each active site of the enzyme, in a location that superposes
506well with part of the 2′-desoxyribose ring of the in silico com-
507plex with dAdo (Fig. 3b). In particular, the oxygen atoms of
508the glycerol molecule superimpose almost perfectly with the
509O3´, O4´, and O5´ atoms of the 2′-deoxyribose and establish
510H-bonds with the side chains of Asp79, Glu85, similarly to the
511complex with dAdo.
512Catalytic activity
513The 2′-deoxyribosyltransferase activity of LmPDTwasmeasured
514for a panel of donors (Urd, Ino, Ado, dUrd, dIno, dAdo, and
515dGuo) and acceptors (Ura, Hyp, Ade, and Gua) (specific activi-
516ties summarized in Table 2). According to the experimental data,
517LmPDT should be classified as 2′-deoxyribosyltransferase type I
518since it catalyzed the transfer of 2′-deoxyribose exclusively be-
519tween purine bases. It did not interchange bases between ribonu-
520cleosides and no activity was detected for the transglycosylation
521reaction between pyrimidine nucleobase as donors and/or
522acceptors.
523It is noteworthy that LmPDT shows much higher specific
524activities than other reported type I NDTs under similar enzy-
525matic assay conditions (Table 2). For instance, for the biosyn-
526thesis of 2′-deoxyadenosine from 2′-deoxyinosine and adenine,
527the specific activity showed by LmPDT (73.1μmolmin−1mg−1)
528was 2.2, 1.7, 20, and 67 times higher than the values of LlNDT
529(42.2 μmol min−1 mg−1) (Becker and Brendel 1996), L. reuteri
530NDT (34 μmol min−1 mg−1) (Fernández-Lucas et al. 2010),
Fig. 2 Amino acid sequence
alignment of LmPDTwith its
closest homologs. LmPDT shares
67% sequence identity to the 2′-
deoxyribosyltransferase from
Trypanosoma brucei (TbNDT),
18% to the 2′-
deoxyribosyltransferase from
Lactobacillus leichmannii




elements in LmPDT are indicated
as orange arrows (β-strands) and
green cylinders (α helices).



















531 Lactococcus lactis NDT (3.6 μmol min−1 mg−1) (Yukiko et al.
532 2 0 0 7 ) , a n d L a c t o b a c i l l u s f e r m e n t u m NDT
533 (1.1 μmol min−1 mg−1) (Kaminski et al. 2008), respectively.
534 The specific activities of LmPDTwere approximately equal re-
535 gardless of the donor, whereas a lower activity was found for
536 guanine as acceptor (Table 2). This finding was corroborated
537 using the same concentration of acceptor and 2′-fluoro-2′-
538 deoxyadenosine as donor.
539 Structural insights explaining the lower activity of
540 LmPDT towards guanine as acceptor when compared to
541 adenine and hypoxanthine were obtained by analyzing
542 the substrate-binding site with the program cGRILL
543 (Cortés-Cabrera et al. 2015). With this aim, affinity maps
544 for the NH4
+ and oxygen probes were calculated for the
545 putative ribosylated form of the enzyme in the absence of
546 the nucleobase. Then, the three nucleobases were manually
547docked into the active site of LmPDT (Fig. 4). Whereas
548Ade and Hyp would orientate their attacking nitrogen N9
549into a favorable region according to the affinity map ob-
550tained with the O probe (red mesh), Gua in its near-attack
551conformation would orientate its carbonyl oxygen and the
552exocyclic amine group into unfavorable affinity regions;
553hence, formation of 2′-deoxyguanosine would be impeded
554on energetic considerations.
555Temperature, pH, and ionic strength dependence
556of LmPDT catalytic activity
557The effects of temperature, pH, and ionic strength dependence
558on the stability and activity of the enzyme were studied to
559determine the optimal operating conditions of the enzyme
560(Fig. 5). On the one hand, the effect of temperature on
561LmPDT activity was examined by measuring the biosynthesis
562of dAdo from dGuo and Ade in the temperature range from 20
563to 90 °C using standard assay conditions. As shown in Fig. 5a,
564high activity (≥ 90%) was achieved between 30 and 70 °C,
565with a maximum value at 40–50 °C. On the other hand, the
566activity of LmPDTwas also examined in the pH range from 4
567to 10 under the same standard assay conditions (Fig. 5b).
568LmPDT displays a great operational activity in a broad range
569of pH (higher than 90% in a pH range from 5.5 to 8.5, and
570higher than 80% in a pH range from 5 to 9). Finally, LmPDT
571retains its catalytic activity at high salt concentrations (90% of
572activity remains at 0.5 M NaCl) (Fig. 5c).
573Enzymatic stability
574The stability of a biocatalyst is defined as the time duringwhich it
575retains 50% of its initial activity and could be affected by
t2:1 Table 2 Synthesis of natural nucleosides catalyzed by LmPDT.
Specific activities (units/mg protein) of LmPDT compared with LhPDT
(Kaminski 2002) and BbPDT (Lawrence et al. 2009)
t2:2                                LmPDT LhPDT BbPDT
t2:3 Acceptor Adea Guab Hypa Adea Guab Hypa Adea Guab Hypa
t2:4 Donor
t2:5 dAdo – 13.8 75.4 – n.p. 0.06 – 0.09 0.02
t2:6 dGuo 52.7 – 68.6 0.05 – 0.05 0.08 – 0.02
t2:7 dIno 73.1 14.5 – 0.08 n.p. – 0.04 0.04 –
n.p. not performed
a Reaction conditions: 0.3 μg of enzyme in 40 μL at 40 °C, 5 min.
(Substrates) = 10 mM, 50 mM MES buffer, pH 6.5
b Reaction conditions, 0.3 μg of enzyme in 40 μL at 40 °C, 5 min.
(Substrates) = 1 mM in 50 mM phosphate buffer, pH 8.5
Fig. 3 Active site of LmPDT. a In silico complex of 2′-deoxyadenosine
(dAdo) bound to LmPDT. Residues from both subunits of LmPDTwould
participate in dAdo-binding, in particular, Asn56, Asp79, andGlu85 from
one subunit and Glu121# and Asn128# from the other. Tyr8 would
properly orientate the Glu85 side chain to interact with the substrate. b
Crystal structure of the complex of LmPDT with glycerol bound within
the active site. Oxygen atoms of the glycerol molecule occupy almost
identical positions as those predicted for the O3´, O4´, and O5´ atoms
from the 2′-deoxyribose ring of dAdo (as semitransparent stick model).
The 2Fo-Fc electron density map is contoured at 1σ. Putative H-bonds are
shown as dashed lines. Distances are in angstrom
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576 environmental conditions such as pH and temperature. In this
577 sense, the temperature and pH effect on LmPDT stability was
578 evaluated by incubating the enzyme for 48 h at 40 °C at different
579 pH conditions (6.5, 8.5, and 10) (Fig. 5d). Regarding the latter
580 parameter, unexpectedly, alkaline environments (pH 8–10) do
581 not inactivate the enzyme during the assayed period.
582Synthesis of non-natural nucleosides
583The synthetic scope of LmPDT was evaluated for the
584glycosyltransfer reaction between several non-natural nucleo-
585sides, such as 2′-fluoro-2′-deoxy-, 2′,3′-dideoxy-, and arabinosyl
586nucleosides using adenine, guanine, and hypoxanthine under
Fig. 5 Biochemical
characterization of LmPDT. a
Effect of temperature on LmPDT
activity (black circle). b Effect of
pH on TtHGXPRT activity, white
triangle sodium acetate 50 mM
(pH 4–6), black circle sodium
phosphate 50 mM (pH 6–8),
white circle sodium borate 50mM
(pH 8–10). c Effect of ionic
strength on TtHGXPRT activity
(black circle). d Thermal
inactivation of TtHGXPRT at
60 °C in sodium borate 50 mM
(pH 8–10), white triangle pH 8,
white circle pH 9, and black circle
pH 10
Fig. 4 Affinity maps calculated
for the NH4+ (blue mesh) and
oxygen (red mesh) probes using
the program cGRILL (29) within
the active site of LmPDTwith a
adenine, b hypoxhantine, or c
guanine considered as acceptors
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587 different assay conditions (Table 3 and Fig. S1). In contrast to
588 the natural substrates, mild conversions were detected in HPLC
589 after 4 and 24 h of reaction. Among the tested donors, 2’F-Ino
590 afforded the highest yields in the transglycosylation to adenine
591 and guanine. To a lesser extent, a similar reactivity was obtained
592 for the dideoxynucleosides ddA and ddI as donors. Finally,
593 when using the arabinosyl nucleosides (ara A, G, and H) as
594 source of glycosyl, the activity of LmPDTwas low.
595 Discussion
596 Purine nucleotides are essential compounds in all living organ-
597 isms. They can be synthesized by the de novo and/or the so-
598 called “salvage” pathways. Unlike their mammalian hosts,
599 most parasites studied lack the pathways for de novo purine
600 biosynthesis and they rely on the salvage pathways to meet
601 their purine demands. Since the final objective of de novo
602 synthesis is the production of inosine-5´-monophosphate
603 (IMP), the absence of this metabolic route demands an efficient
604 alternative to synthesize IMP (el Kouni 2003). Most parasites
605 circumvent this problem by an efficient and complex purine
606 salvage pathway, formed by a substantial number of enzymes,
607 such as nucleoside hydrolases, nucleoside phosphorylases, nu-
608 cleoside kinases, 2´-deoxyribosyltransferases, deaminases, or
609 phosphoribosyltransferases with the potential to be involved in
610 cleaving, assembling, and interconverting scavenged nucleo-
611 sides and nucleobases in parasites (el Kouni 2003).
612 Since inosine and xanthosine kinases are detected in a low
613 amount in Leishmania species (Datta et al. 2008), phosphor-
614 ylation of inosine seems to be a non-efficient way for the IMP
615 synthesis. In addition, adenosine deaminase, which catalyzes
616 the conversion of adenosine to inosine, is only present in
617 Leishmania amastigotes (Datta et al. 2008). Due to this,
618ribophosphorylation of hypoxanthine by hypoxanthine-
619guanine phosphoribosyltransferase (HGPRT) seems to be the
620most effective synthetic route for IMP synthesis.
621One of the processes of purine recycling entails the removal
622of the ribose or 2′-deoxyribose moiety from purine nucleosides
623through the cleavage of C-N glycosidic bond. This process is
624accomplished by at least three types of enzymes: purine nucle-
625oside phosphorylases, PNPs (EC 2.4.2.1); purine nucleoside
626hyd ro l a s e s , NHs (EC 3 .2 . 2 . 1 ) ; o r nuc l e o s i d e
627deoxyribosyltransferases, NDTs (EC 2.4.2.6). The presence of
628PNPs is not reported in Leishmania, and NHs are strictly spe-
629cific for ribonucleosides, with negligible activity over 2′-
630deoxyribonucleosides (Shi et al. 1999; Versées and Steyaert
6312003), so NDTs is the only effective way to recover hypoxan-
632thine. In addition, several lines of evidence suggest a specific
633role of PDT in the eradication of dIno from the cellular nucleo-
634side pool by converting dIno to hypoxanthine, which can then
635be recycled to IMP by hypoxanthine phosphoribosyltransferase
636(Fresco-Taboada et al. 2013; Kaminski 2002; Steenkamp and
637Hälbich 1992).
638Here, we have reported a thorough functional and structural
639characterization of the purine 2′-deoxyribosyltransferase of
640L. mexicana (LmPDT). Analysis of the LmPDT structure and
641sedimentation velocity experiments reveals that the protein is a
642dimer similarly to TbNDT but in contrast to the bacterial, ho-
643molog enzymes LlNDT and LhPDT, which are homohexamers
644(trimers of dimers), revealing a marked pleomorphism within
645this family of proteins. The hexameric assembly of LlNDT and
646LhNDT belongs to the D3 dihedral group (Goodsell and Olson
6472000) since it contains a threefold rotational symmetry axis
648perpendicular to a twofold axis (Fig. 6). Molecular interfaces
649between subunits related by the twofold axis result from the
650antiparallel stacking of α4 and α4# helices and the penetration
651of the α6 helix and the three C-terminal residues between the
652α3# and α4# helices (Fig. 6a). Not surprisingly, these interfaces
653are essentially conserved in the four proteins (LmPDT, TbNDT,
654LhPDT, and LlNDT) since they are responsible for the built-up
655of the dimeric assembly, the basic catalytic unit of this family of
656proteins (Armstrong et al. 1996) (Fig. 6b). Nonetheless, an im-
657portant difference is observed between hexameric and dimeric
658enzymes regarding these common interfaces. In particular, sim-
659ilar intersubunit interactions identified in LhPDT and LlNDT
660involving the C-terminal residues are observed neither in
661LmPDT nor in TbNDTwhat is remarkable since the carboxylate
662group of the C-terminal residue of LhPDT has been shown to
663play an important catalytic role (Anand et al. 2004). As indicated
664above, this role is now probably played by Glu121#, which
665occupy a similar location in LmPDT. Conversely, the main
666contacting interfaces between subunits related by the perpendic-
667ular threefold axis in LlNDTand LhPDTare formed byα3 helix
668that packs against a long C-terminal, irregular segment of the
669neighbor subunit (comprised by residues 155–162 in LhNDT
670and 146–151 in LlNDT) and only for LhPDT also by the side-
t3:1 Table 3 Synthesis of nucleoside analogues catalyzed by LmPDT
t3:2 Acceptor Aden Guab Hypa
t3:3 4 h 24 h 4 h 24 h 4 h 24 h
t3:4 Donor
t3:5 ddA – – 10% 52% 11% 57%
t3:6 ddI 46% 20% 20% 6% – –
t3:7 ara A – – n.p. 10% n.p. 9%
t3:8 ara G n.p. 30% – – n.p. 16%
t3:9 ara H n.p. 25% – 6% – –
t3:10 2’F-Ino 15% 57% 18% 61% – –
n.p. not performed
a Reaction conditions, 3 μg of enzyme in 40 μL at 40 °C, 4–24 h.
(Substrates) = 1 mM, 50 mM MES buffer, pH 6.5
b Reaction conditions, 3 μg of enzyme in 40 μL at 40 °C, 4–24 h.
(Substrates) = 1 mM, 50 mM sodium borate 50 mM, pH 8.5
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671 by-side interaction between the β2 strand and the four N-
672 terminal residues of the accompanying subunit. As expected,
673 key structural elements involved in trimer stabilization are not
674 present in LmPDT (Fig. 6d).
675 Within dihedral oligomers, novel interfaces may appear be-
676 tween subunits not related by rotational symmetry (Goodsell
677 and Olson 2000). In the case of LlNDT and LhPDT hexamers,
678 this type of contacts is represented by interfaces between ele-
679 ments that belong neither to the same dimer nor to the same
680 trimer. These types of contacts are exemplified here by interac-
681 tions between the N-terminal ends of α3 helices from subunits
682 not related by the rotational, molecular symmetry (Fig. 6a, c).
683 This is consistent with our observation that α3 helices from the
684 hexameric enzymes are much longer than the equivalent from
685 dimeric ones. This observation suggests that from a structural
686 point of view, the stabilization of the hexameric assembly of
687 LlNDT and LhPDT demands a long β2-α3 connecting loop
688 (LhPDT; Fig. 6E), or connecting region (LlNDT; Fig. 6F), de-
689 rived from their much longer α3 helices. We believe that this is
690 relevant because this region is located above the substrate-
691binding pockets of LlNDT and LhNDT and plays an important
692role in the definition of the substrate specificity of class I versus
693class II N-deoxyribosyltransferases (Anand et al. 2004). Since
694the much shorter connecting loop of LmPDT or TbNDT en-
695zymes does not cover their active sites, its specific functional
696role in LlNDTand LhPDTshould be understood as an emergent
697feature that most probably results from the interplay between
698optimization of interactions within the higher order oligomeric
699assemblies endowed with D3 symmetry and their catalytic
700activity.
701The poor electron density of the side chains of some residues
702from the much shorterβ2-α3 loop in LmPDT (Asp43 to Ala46)
703suggests that it is flexible. Our combined crystallographic and in
704silico studies suggest that the dynamic features of this loop may
705be important in substrate binding. Hence, whereas the confor-
706mation of this loop in the absence of bound substrate is revealed
707by the structure of LmPDT, our molecular dynamics studies
708suggest that the conformation of this loop with dAdo bound
709within the active site progresses towards the conformation found
710in the TbNDT structure (Fig. S2 and supplementary video 1).
Fig. 6 Molecular symmetry of
the hexameric assembly of
Lactobacillus helveticus 2′-
deoxyribosyltransferase (LhPDT)
and structural comparison with
the LmPDT subunit. a, b
Orthogonal views of the hexamer
of LhPDT. The twofold molecular
symmetry axis is shown as an
orange ellipse and the threefold
axis as a black triangle; both axes
are perpendicular to the plane of
the figure. Blue circles indicate
the contacting regions between
subunits related by the threefold
symmetry axis and red stars
contacting regions not related by
the molecular symmetry (see text
for details). To facilitate the
interpretation and also the
comparison with LmPDT, a dimer
of LhPDT is highlighted with
yellow and green subunits. c, d
The same views as before but
indicating the relative position of
the LmPDT dimer (as surface
model; one subunit green and the
other yellow). Three-dimensional
superposition of the LmPDT
subunit (orange) with the LhPDT
subunit (blue) (e) and LlNDT
(magenta) (f). Helices are shown
as solid cylinders andβ-strands as
arrows. The figures have been
prepared with PyMOL (DeLano
2002)
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711 The calculated specific activity values of LmPDT are much
712 higher than those reported for other PDTs, such as LhPDT or
713 PDT from Borrelia burgdorferi, BbPDT (between 100- or
714 4000-fold higher in the same experimental conditions;
715 Table 2). A putative explanation for these higher activities could
716 be found in the essential physiological role of nucleoside
717 deoxyribosyltransferases in the purine salvage pathway in
718 Leishmania species since, as described above, these enzymes
719 constitute the only effective way to recover hypoxanthine in
720 parasites. By contrast, other microorganisms have alternative
721 synthetic routes for IMP synthesis: for instance, in Borrelia
722 burgdorferi, adenosine deaminases and deoxynucleoside ki-
723 nases have been reported (Lawrence et al. 2009), and in
724 L. helveticus 2′-deoxyribosyltransferases (NDTs and PDTs),
725 as well as an adenosine deaminase have been identified
726 (Kaminski 2002).
727 Yet the most remarkable biochemical feature of LmPDT is
728 its stability at high pH and temperature values; in fact, as far as
729 we know, it is the first time that this high tolerance to alkaline
730 conditions is reported for an NDT. We believe that this is
731 relevant since one of the most limiting factors for the industrial
732 synthesis of purine nucleosides is the low solubility of some
733 purine bases (guanine, hypoxanthine, and/or xanthine) in the
734 reaction medium. Our results suggest that LmPDT may be an
735 interesting alternative to circumvent this problem.
736 Furthermore, this non-usual stability at high pH values en-
737 tails another significant advantage. Since enzyme immobiliza-
738 tion is an essential requirement for the use of enzymes as
739 industrial biocatalysts, enzyme stability under immobilization
740 conditions is necessary. Covalent immobilization of proteins
741 usually occurs via multipoint attachment through the region
742 with higher density of primary amino groups, especially with
743 ε-NH2 from lysine residues (Mateo et al. 2007). Due to this,
744 covalent immobilization techniques usually employ long re-
745 action times (2–24 h) and alkaline conditions (pH 8–10). In
746 this way, the exceptional stability displayed by LmPDT in
747 alkaline conditions suggests that it could be efficiently
748 immobilized.
749 The only precedent of an enzyme-based synthesis of 2′-
750 deoxyguanosine was described by Okuyama et al. (2003) and
751 was based on the multi-enzymatic system LhNDT/EcADA.
752 Regarding to its potential applicability in the industrial synthesis
753 of nucleoside analogues, it is obvious that the one-step action of
754 LmPDT is a priori a simpler scenario than the coupling system
755 LhNDT/EcADA since the latter would require the co-
756 immobilization of the LhNDT and EcADA enzymes to perform
757 the reaction.
758 As a proof of concept, LmPDTwas employed as biocatalyst
759 for the synthesis of different therapeutic nucleoside analogues
760 (Table 3) (Fig. S1), such as 2′,3′-dideoxyguanosine (ddG—a
761 selective inhibitor of the replication of human immunodeficien-
762 cy virus in vitro and an active antihepadnavirus nucleoside
763 analogue) (Bondoc et al. 1992), 2′,3′-dideoxyinosine (ddI,
764didanosine, a potent inhibitor of HIV replication) (World
765Health Organization 2011), 9-β-D-arabinofuranosyl adenine
766(ara A, vidarabine, not only an antiviral drug which is active
767against herpes simplex and varicella zoster viruses, but a poten-
768tial precursor of fludarabine and clofarabine, approved FDA
769drugs for the cancer treatment) (De Clerq 2005a, b; Galmarini
770et al. 2002; Parker 2009; Wilhelmus 2015), 9-β-D-
771arabinofuranosyl guanine (ara G, precursor of nelarabine, ap-
772proved FDA drugs for the cancer treatment of T cell malignan-
773cies) (Parker 2009), and 2′-fluoro-2′-deoxyguanosine (2’F-
774dGuo, an anti-influenza virus agent) (Tuttle et al. 1993).
775Although in low conversions compared to the natural sub-
776strates, we detected the expected, final products. This is remark-
777able since to date no wild-type NDT has been described to
778perform the synthesis of 2′,3′-dideoxyribonucleosides despite
779the fact that wild-type NDTs from L. helveticus (Carson and
780Wasson 1988), L. fermentum, and L. leichmannii (Kaminski
781et al. 2008) recognize this type of molecules with very low
782affinity. Finally, our results also reveal that LmPDT bind 2’F-
783dGuo and arabinosyl nucleosides. This means that the binding
784site tolerates the presence of a fluorine atom or a hydroxyl
785group at position 2′ of the sugar ring. All these particularities,
786together with its high activity and stability in alkaline condi-
787tions, make LmPDT the first reported NDT able to catalyze the
788synthesis of 2’F-dGuo, ara G and ara H.
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AUTHOR PLEASE ANSWER ALL QUERIES.
Q1. The sentence "Conversely, although in the active site of LmPDT..." was slightly modified. Please
check if correct.
Q2. Please check whether in the references all species names are typeset in italics.
Q3. Please replace the country name with the city name for the publisher’s location.
